COVID-19 Testing in Less than 5 Minutes Using Novel RTF-EXPAR Method

The assay time is considerably reduced from about an hour to few minutes by the newly reported RTF-EXPAR method which uses reverse transcriptase-free (RTF) approach for conversion of RNA into DNA followed by EXPAR (Exponential Amplification Reaction) for amplification at single temperature.

Controlling the rate of COVID-19 spread requires an accurate and a faster virus testing strategy. RT-PCR (reverse transcriptase polymerase chain reaction), the most accurate testing method being currently employed is a two-step test that takes around 60 minutes per sample.  

The researchers from the University of Birmingham have reported a novel method for detection of SARS-CoV-2. This could enable much faster testing and is sufficiently sensitive.  

The viral RNA detection by RT-PCR (reverse transcriptase polymerase chain reaction) involves conversion of viral RNA to complementary DNA (cDNA) followed by amplification of cDNA by a quantitative PCR (qPCR). The cDNA is then detected using a fluorescent dye. This takes up to an hour. 

The assay time is considerably reduced from about an hour to few minutes by the newly reported RTF-EXPAR method which uses reverse transcriptase-free (RTF) approach for conversion of RNA into DNA followed by EXPAR (Exponential Amplification Reaction) for amplification at single temperature. The amplification taking place at a single temperature is the key to speed, because it avoids lengthy heating and cooling steps of RT-PCR. Further, the section of DNA being amplified is smaller compared RT-PCR. Hence, EXPAR generates up to 108 strands of DNA product in few minutes. The duplex formation is monitored, as in RT-PCR method using fluorescent dye, SYBR Green.  

Interestingly, the new method can be modified to detect several other infectious diseases caused by RNA viruses, for example Ebola, RSV, etc.  

Source(s):  

Carter et al (2020).  Sub-5-minute Detection of SARS-CoV-2 RNA using a Reverse Transcriptase-Free Exponential Amplification Reaction, RTF-EXPAR. Preprint. Published at medRxiv Posted January 04, 2021. DOI: https://doi.org/10.1101/2020.12.31.20248236 

***

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

45 Years of Climate Conferences  

From first World Climate Conference in 1979 to COP29...

COVID-19 in 2025  

The unprecedented COVID-19 pandemic spanning over three years claimed...

Early Solar System had Widespread Ingredients for Life

The asteroid Bennu is an ancient carbonaceous asteroid that...

Science, Truth, and Meaning

The book presents a scientific and philosophical examination of...

Antimicrobial resistance (AMR): a novel antibiotic Zosurabalpin (RG6006) shows promise in pre-clinical trials

Antibiotic resistance particularly by Gram-negative bacteria has nearly created a...

Scientific European -An Introduction

Scientific European® (SCIEU)® is a monthly popular science magazine...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...

1 COMMENT

Comments are closed.